Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Mono Pharmacare IPO is a book build issue of ₹14.84 crores. The issue is entirely a fresh issue of 0.53 crore shares of ₹14.84 crore.
Mono Pharmacare IPO bidding started from Aug 28, 2023 and ended on Aug 30, 2023. The allotment for Mono Pharmacare IPO was finalized on Sep 4, 2023. The shares got listed on NSE SME on Sep 7, 2023.
Mono Pharmacare IPO price band is set at ₹28.00 per share . The lot size for an application is 4,000. The minimum amount of investment required by an retail is ₹1,04,000 (4000 shares). The minimum lot size investment for HNI is 2 lots (8,000 shares), amounting to ₹2,24,000.
Unistone Capital Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The market maker of the company is Rikhav Securities Ltd..
Refer to Mono Pharmacare IPO RHP for detailed Information.
| IPO Date | August 28, 2023 to August 30, 2023 |
| Listing Date | September 7, 2023 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹26 to ₹28 per share |
| Issue Price Final | ₹28 per share |
| Lot Size | 4,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 53,00,000 shares (aggregating up to ₹14.84 Cr) |
| Reserved for Market Maker | 2,76,000 shares Rikhav Securities Ltd. (aggregating up to ₹0.7728 Cr) |
| Net Offered to Public | 50,24,000 shares (aggregating up to ₹14.07 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,23,68,564 shares |
| Share Holding Post Issue | 1,76,68,564 shares |
Mono Pharmacare IPO offers total 53,00,000 shares. Out of which 5,00,000 (9.43%) allocated to QIB, 22,60,000 (42.64%) allocated to NII, 22,64,000 (42.72%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 2,76,000 (5.21%) |
| QIB Shares Offered | 5,00,000 (9.43%) |
| NII (HNI) Shares Offered | 22,60,000 (42.64%) |
| Retail Shares Offered | 22,64,000 (42.72%) |
| Total Shares Offered | 53,00,000 (100.00%) |
Mono Pharmacare IPO opens on August 28, 2023, and closes on August 30, 2023.
| IPO Open Date | Mon, Aug 28, 2023 |
| IPO Close Date | Wed, Aug 30, 2023 |
| Tentative Allotment | Mon, Sep 4, 2023 |
| Initiation of Refunds | Tue, Sep 5, 2023 |
| Credit of Shares to Demat | Wed, Sep 6, 2023 |
| Tentative Listing Date | Thu, Sep 7, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Wed, Aug 30, 2023 |
Investors can bid for a minimum of 4,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4,000 | ₹1,12,000 |
| Retail (Max) | 1 | 4,000 | ₹1,12,000 |
| HNI (Min) | 2 | 8,000 | ₹2,24,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 1994, Mono Pharmacare Limited is engaged in the business of marketing and distribution of pharmaceutical products.
The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac - Diabetic medicines, and cosmocare products.
Mono Pharmacare works with contract manufacturers to manufacture pharmaceutical products to sell them under their brand name DLS Export. The company acquired DLS Export in 2022, for an aggregate consideration of ₹ 609 lakhs, in order to grow its product portfolio in selected therapeutic areas.
As on February 28, 2023, the company has over 168 pharmaceutical companies as their distributors and stockists and also, and served over 3,036 customers/vendors who are a mix of retail pharmacy stores as well as wholesalers.
| Period Ended | 31 Mar 2020 | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
| Assets | 871.70 | 1,122.46 | 1,438.31 | 6,257.39 |
| Total Income | 1,168.90 | 2,837.83 | 3,710.27 | |
| Profit After Tax | 1.99 | 9.51 | 35.09 | |
| Net Worth | 201.92 | 369.58 | 427.57 | |
| Reserves and Surplus | 131.71 | |||
| Total Borrowing | 633.46 | 608.03 | 643.93 |
The market capitalization of Mono Pharmacare IPO is ₹49.47 Cr.
| KPI | Values |
|---|---|
| ROE | 9.01% |
| ROCE | 10.34% |
| Debt/Equity | 2.92 |
| RoNW | 9.01% |
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
[Dilip Davda] The company is a distributor for many giant pharma companies and has been doing well for the reported periods. Based on FY23 earnings, the issue appears aggressively priced. Well-informed investors may park funds for the medium to long-term rewards. Read detail review...
| Listing Date | September 7, 2023 |
| BSE Script Code | |
| NSE Symbol | MONOPHARMA |
| ISIN | INE0OIP01012 |
| Final Issue Price | ₹28 per share |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹28.00 |
| Open | ₹29.00 |
| Low | ₹29.00 |
| High | ₹30.45 |
| Last Trade | ₹30.45 |
Mono Pharmacare Ltd.
1A, Krinkal Apartment Opp.
Mahalaxmi Temple,
Paldi,
Ahmedabad, Gujarat, 380007
Phone: +91 99780 41356
Email: cs@monopharmacareltd.com
Website: https://monopharmacareltd.com/
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Mono Pharmacare IPO is a SME IPO of 53,00,000 equity shares of the face value of ₹10 aggregating up to ₹14.84 Crores. The issue is priced at ₹28 per share. The minimum order quantity is 4000.
The IPO opens on August 28, 2023, and closes on August 30, 2023.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Mono Pharmacare IPO using UPI as a payment gateway. Zerodha customers can apply in Mono Pharmacare IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Mono Pharmacare IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Mono Pharmacare IPO opens on August 28, 2023 and closes on August 30, 2023.
Mono Pharmacare IPO lot size is 4000, and the minimum amount required for application is ₹1,12,000.
You can apply in Mono Pharmacare IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Mono Pharmacare IPO will be done on Monday, September 4, 2023, and the allotted shares will be credited to your demat account by Wednesday, September 6, 2023. Check the Mono Pharmacare IPO allotment status.
The Mono Pharmacare IPO listing date is on Thursday, September 7, 2023.
Useful Articles
RHP